Minerva Neurosciences
NERV
18 hedge funds and large institutions have $51M invested in Minerva Neurosciences in 2015 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 4 closing their positions.
75% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 4
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
47% more capital invested
Capital invested by funds: $34.7M → $51M (+$16.3M)
20% more funds holding
Funds holding: 15 → 18 (+3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
+$6.63M |
| 2 |
DADC
D.A. Davidson & Co
Great Falls,
Montana
|
+$407K |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$167K |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$112K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$107K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$1.01M |
| 2 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$507K |
| 3 |
SIM
Spark Investment Management
New York
|
-$140K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
-$89K |
| 5 |
Citigroup
New York
|
-$4K |
NERV Hedge Fund Activity: Q2 2015 in Review
18 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q2 2015, worth a combined $51M — up 47% from $34.7M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new NERV positions and 4 closed out — a net gain of 3 holders — while 5 added to existing stakes and 3 trimmed.
The largest buyer was Highland Capital Management (Texas), opening a new position worth an estimated $6.63M. The largest seller was Armistice Capital, exiting entirely with an estimated $1.01M sold.
- 18 institutional investors held Minerva Neurosciences (NERV) as of Q2 2015, up from 15 in Q1 2015.
- Funds reported $51M of Minerva Neurosciences stock for Q2 2015, up 47% quarter-over-quarter.
- 7 funds opened new Minerva Neurosciences positions in Q2 2015 and 4 closed out, a net change of +3 holders.
- The largest Minerva Neurosciences buyer in Q2 2015 was Highland Capital Management (Texas), an estimated $6.63M added.
- The largest Minerva Neurosciences seller in Q2 2015 was Armistice Capital, an estimated $1.01M sold.
Based on aggregated 13F filings for Q2 2015.